antisense oligonucleotides miR-122 (Regulus/GSK)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameantisense oligonucleotides miR-122 (Regulus/GSK)
Drug Alias Nameanti-miR-122 antisense oligonucleotide (Regulus)antisense oligonucleotides miR-122 (Regulus)antisense oligonucleotides miR-122 (Isis)ASO-1ASO-11 +[7] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionAntisense oligonucleotide inhibitorsHepatitis C virus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsFatty LiverHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRegulus Therapeutics IncIonis Pharmaceuticals IncGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsFatty LiverHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A